세계의 저침습수술(MIS) 로봇 시스템 시장 규모는 2024년에는 81억 달러에 달했습니다. 이 시장은 15.9%의 CAGR로 확대하며, 2031년에는 230억 달러에 달할 것으로 예측됩니다.
Intuitive Surgical은 역사적으로 우위를 차지하며 왔으나, 경쟁 격화에 직면하고 있습니다. CMR Surgical, Medtronic, SS Innovations, Distalmotion 등의 신규 기업이 시장에서의 존재감을 높이고 있습니다.
임상 적응의 확대에는 규제기관의 승인 프로세스에 시간이 걸립니다. 신규 참여 기업임에도 불구하고 Intuitive Surgical은 조기 시장 참여와 확립된 브랜드에 의해 강력한 지위를 유지하고 있습니다.
세계의 저침습수술(MIS) 로봇 시스템 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
The global MIS robotic system market was valued at $8.1 billion in 2024 and is expected to grow at a CAGR of 15.9%, reaching $23 billion by 2031.
This market is divided into three key segments:
Market insights & data coverage
Market trends & challenges
* New entrants are reshaping market dynamics
* Intuitive Surgical has historically dominated but faces rising competition.
* Emerging companies like CMR Surgical, Medtronic, SS Innovations, and Distalmotion are expanding market presence.
* Expanding clinical indications requires a lengthy regulatory approval process.
* Despite new players, Intuitive Surgical maintains a strong position due to its early market entry and established brand.
Market segmentation & growth trends
* Largest segment in 2024 and expected to grow the fastest.
* Growth driven by the increasing number of procedures and installed robotic systems.
* Second-largest segment in 2024 but growing at a slower rate.
* Market saturation in North America is limiting new sales.
* Smallest segment in 2024 and projected to lose market share.
* Still experiencing growth due to increasing installed base.
Market share insights
Top competitors in the global MIS robotic system market (2024):
1 Intuitive Surgical - Market leader in MIS robotic systems
* Pioneered da Vinci(R) robotic systems since 2000.
* Current lineup includes da Vinci(R) Xi, da Vinci(R) X, and da Vinci(R) SP.
Also markets Ion(TM), a robotic platform for minimally invasive lung biopsies.
2 CMR Surgical - Expanding global footprint
* Reported over 27,000 procedures using its Versius robot.
* Covers Europe, Latin America, Asia, Middle East, and Africa.
* Received FDA clearance in October 2024 for gallbladder removal indication.
3 Medtronic - Strengthening position in robotic-assisted MIS
* Launched Hugo(TM) RAS in 2021.
* Commercially available in select regions, but still investigational in the U.S.
* Strong brand reputation in the medical device industry supports future growth.
Market segmentation summary
Global research scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative coverage
Qualitative coverage
Data sources